1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione

C30H36N2O6 — CID 98556843

IUPAC1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione
SMILESC[C@@]12[C@@H]3[C@H]4[C@@H]5[C@H]6[C@H]7[C@@H](CC[C@H]7O[C@@H](N7C(=O)CCC7=O)[C@]6(C)[C@H]4[C@H]4CC[C@@H](O[C@@H]1N1C(=O)CCC1=O)[C@@H]43)[C@H]52
InChIInChI=1S/C30H36N2O6/c1-29-23-11-3-5-14-20(11)26-21(23)22-24(30(26,2)28(38-14)32-17(35)9-10-18(32)36)12-4-6-13(19(12)25(22)29)37-27(29)31-15(33)7-8-16(31)34/h11-14,19-28H,3-10H2,1-2H3/t11-,12+,13-,14-,19-,20+,21+,22+,23-,24+,25+,26-,27+,28-,29-,30-/m1/s1
InChIKeyWHKWKQIREHTRPI-CVRPGYSGSA-N
MW520.63 g/mol
LogP2.55
Rot. Bonds2

About 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione

1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione (PubChem CID 98556843) has the molecular formula C30H36N2O6 and a molecular weight of 520.63 g/mol. Its IUPAC name is 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione.

Molecular Properties

Compound Name1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione
PubChem CID98556843
Molecular FormulaC30H36N2O6
Molecular Weight520.63 g/mol
Exact Mass520.26
IUPAC Name1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione
SMILESC[C@@]12[C@@H]3[C@H]4[C@@H]5[C@H]6[C@H]7[C@@H](CC[C@H]7O[C@@H](N7C(=O)CCC7=O)[C@]6(C)[C@H]4[C@H]4CC[C@@H](O[C@@H]1N1C(=O)CCC1=O)[C@@H]43)[C@H]52
InChIInChI=1S/C30H36N2O6/c1-29-23-11-3-5-14-20(11)26-21(23)22-24(30(26,2)28(38-14)32-17(35)9-10-18(32)36)12-4-6-13(19(12)25(22)29)37-27(29)31-15(33)7-8-16(31)34/h11-14,19-28H,3-10H2,1-2H3/t11-,12+,13-,14-,19-,20+,21+,22+,23-,24+,25+,26-,27+,28-,29-,30-/m1/s1
InChIKeyWHKWKQIREHTRPI-CVRPGYSGSA-N
XLogP2.55
TPSA93.22 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms38
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500520.63
LogP ≤ 52.55
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(1R,2S,3S,4S,7S,10R,11S,12R,13S,14R,15S,18R,21R,22S)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosane-9,20-dione
CID 124911580
(1R,2R,3R,4S,7S,10S,11S,12R,13S,14R,15S,18R,21S,22S)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosane-9,20-dione
CID 124911582
N'-[(1S,2S,3R,4S,7R,9S,10S,11R,12S,13S,14R,15R,18S,20S,21S,22S)-10,21-dimethyl-20-[[4-(methylamino)-4-oxobutanoyl]amino]-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]-N-methylbutanediamide
CID 98558281
(1R,2S,3S,5R,7R,10S,11S,12S,13R,14R,15R,16R,18R,21S,22S,23R)-5-methoxy-15-methyl-6,17-dioxanonacyclo[11.10.0.02,21.03,12.03,16.07,11.010,14.015,23.018,22]tricosane
CID 98556862
(1S,2S,3S,5S,7S,10S,11R,12R,13S,14S,15S,16S,18S,21S,22R,23S)-5-methoxy-15-methyl-6,17-dioxanonacyclo[11.10.0.02,21.03,12.03,16.07,11.010,14.015,23.018,22]tricosane
CID 124911247
(1R,2R,3R,5S,7S,10R,11R,12S,13R,14S,15R,17S,19S,22S,23R,24S)-6,18-dioxadecacyclo[11.11.0.02,22.03,5.03,12.07,11.010,14.015,17.015,24.019,23]tetracosane
CID 98556835
(1S,2R,3S,5R,7R,10R,11S,12R,13S,14S,15S,17R,19S,22R,23S,24R)-4,6,16,18-tetraoxadecacyclo[11.11.0.02,22.03,5.03,12.07,11.010,14.015,17.015,24.019,23]tetracosane
CID 124920895
(1R,2R,3R,5S,7S,10R,11R,12S,13R,14S,15R,17S,19R,22S,23S,24S)-6,18-dioxadecacyclo[11.11.0.02,22.03,5.03,12.07,11.010,14.015,17.015,24.019,23]tetracosane
CID 98556836
(1R,2S,3S,4R,7R,9R,10R,11S,12S,13R,14S,15S,18S,20R,21S,22S)-9,20-dimethoxy-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosane-10,21-diol
CID 98556867
1-[(1R,2S,6R,7S,8R)-4,4-dimethyl-3,5,9,11-tetraoxatricyclo[6.2.1.02,6]undecan-7-yl]pyrrolidine-2,5-dione
CID 101157560
1-[2-(2,5-dioxopyrrolidin-1-yl)cyclohexyl]pyrrolidine-2,5-dione
CID 118894944
2-methylpentacyclo[6.4.0.02,10.03,7.04,9]dodecane
CID 147978015

Frequently Asked Questions

What is the IUPAC name of 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione?
The IUPAC name of 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione (CID 98556843) is 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione.
What is the SMILES notation for 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione?
The canonical SMILES for 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione is C[C@@]12[C@@H]3[C@H]4[C@@H]5[C@H]6[C@H]7[C@@H](CC[C@H]7O[C@@H](N7C(=O)CCC7=O)[C@]6(C)[C@H]4[C@H]4CC[C@@H](O[C@@H]1N1C(=O)CCC1=O)[C@@H]43)[C@H]52.
What is the InChIKey of 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione?
The InChIKey is WHKWKQIREHTRPI-CVRPGYSGSA-N. The full InChI is InChI=1S/C30H36N2O6/c1-29-23-11-3-5-14-20(11)26-21(23)22-24(30(26,2)28(38-14)32-17(35)9-10-18(32)36)12-4-6-13(19(12)25(22)29)37-27(29)31-15(33)7-8-16(31)34/h11-14,19-28H,3-10H2,1-2H3/t11-,12+,13-,14-,19-,20+,21+,22+,23-,24+,25+,26-,27+,28-,29-,30-/m1/s1.
What are the key properties of 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione?
1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione has a molecular weight of 520.63 g/mol, XLogP of 2.55, 2 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(1S,2S,3R,4S,7R,9R,10R,11S,12S,13R,14S,15R,18R,20S,21R,22R)-20-(2,5-dioxopyrrolidin-1-yl)-10,21-dimethyl-8,19-dioxaoctacyclo[10.10.0.02,10.03,7.04,22.011,15.013,21.014,18]docosan-9-yl]pyrrolidine-2,5-dione is sourced from PubChem (CID 98556843), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).